Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

NEOGENESYS 2K

K-Number: K022433 · 2003-01-24

Decision Date2003-01-24
Product CodeLIH
Advisory CommitteeNE
DecisionSubstantially Equivalent

Device Summary

NEOGENESYS 2K is the device name listed in this FDA 510(k) record. The listed applicant is Sanexas Intl. GmbH. It received FDA 510(k) clearance on 2003-01-24 under 510(k) number K022433. The device is classified under product code LIH. It was reviewed by the NE advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the NEOGENESYS 2K?

NEOGENESYS 2K is a medical device that received FDA 510(k) clearance on 2003-01-24. The listed applicant is Sanexas Intl. GmbH. The 510(k) number is K022433.

When did NEOGENESYS 2K receive FDA 510(k) clearance?

NEOGENESYS 2K received FDA 510(k) clearance on 2003-01-24, under 510(k) number K022433.

Who is the listed applicant for NEOGENESYS 2K?

The FDA 510(k) record lists Sanexas Intl. GmbH as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for NEOGENESYS 2K?

The FDA product code for NEOGENESYS 2K is LIH.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Related Devices (Code: LIH)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑